3-[n-butyl-n-acetyl]-aminopropionic acid ethyl ester
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 10, 2019 (NCT03813069)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04419766 | N/A | Sep 30, 2020 | Centro de Investigação Operacional da Beira, INS, MISAU, Mozambique, Fundação Belmiro de Azevedo, Portugal, Universidade Nova de Lisboa |
| NCT03813069 | Phase 2 | Jan 10, 2019 | Government of Ethiopia, The Fred Hollows Foundation, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centro de Investigação Operacional da Beira, INS, MISAU, Mozambique | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Fundação Belmiro de Azevedo, Portugal | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Government of Ethiopia | Government | 1 | 0 | 1 | 2019 |
| The Fred Hollows Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Universidade Nova de Lisboa | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2019 |
6 organizations
Page 1 / 1